Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
0.1277 USD | -3.11% | -9.43% | -78.35% |
% 1. Jan. | Kap. | |
---|---|---|
-78.35% | 6.21 Mio. | |
+51.85% | 59.28 Mrd. | |
+41.42% | 40.94 Mrd. | |
-5.25% | 40.17 Mrd. | |
-5.16% | 28.69 Mrd. | |
+12.79% | 26.63 Mrd. | |
-20.18% | 18.89 Mrd. | |
+30.88% | 12.46 Mrd. | |
+0.61% | 12.42 Mrd. | |
+25.06% | 12.26 Mrd. |
- Börse
- Aktien
- A2P21Z Aktie
- Nachrichten NLS Pharmaceutics AG
- Mazindol ER-Studie von NLS Pharmaceutics geht in Phase 3 über